The number of cancer cases is emerging across the U.S. and the world. Breast and cervical cancer are one of the most leading diseases liable for the death of hundreds of thousands of women. Particularly, cervical cancer has become a public health concern within the past twenty to thirty years. But now it seems like the circumstances are transforming. According to a new study, the U.S. is on the way to conquer cervical cancer as a public health threat. Scientists say cervical cancer can be eradicated at existing levels of HPV (human papillomavirus) and testing. As per the trial, by 2023-2043, the U.S. could have reduced cases, may be less than four per 100,000 females. The team says it is possible to accelerate the process by 10-13 years by increasing screening scope by 90%.
The study includes the participation of scientists from the Harvard T.H. Chan School of Public Health. While reporting the finding in The Lancet Public Health, the researches have used two different disease modeling prototypes. They have equated nine distinct combinations of HPV Vaccination and cervical cancer testing scope with existing phases of the practices. Raising testing coverage of cervical cancer has brought the estimated period of eradication forward. But the researchers have not found the same fact in the case of the HPV injection.
Emily Burger, the co-author of the study, said the HPV vaccination would play a crucial role in lessening the pressure of cervical cancer across the US. Also, the authors of the study have noted that their discovery does not recommend that efforts to raise vaccination coverage are needless. It is not the speediest approach to reduce cervical cancer cases in the U.S. as it takes time to detect HPV-related cancers, including cervical cancer. Jane Kim, a co-author of the study, said they have discovered that even without any novel attempt towards boosting screening or vaccination, they can succeed to eliminate cervical cancer in the upcoming two decades. In the end, the team anticipates that the discovery will stimulate public health authorities to comprehend the importance of investments in these preventive schemes.